Fenfluramine-induced immunosuppression: an in vivo analysis

Area of Science:

• Immunology
• Pharmacology
• Neuroscience

Background:

• Cytokines play a crucial role in immune responses.
• Fenfluramine is known to affect neurotransmitter systems and the hypothalamic-pituitary-adrenal (HPA) axis.
• Understanding the immunomodulatory effects of drugs is vital for therapeutic applications.

Purpose of the Study:

• To investigate the immunomodulatory potential of acute fenfluramine administration.
• To determine the mechanisms underlying fenfluramine-induced changes in cytokine production.
• To assess the role of glucocorticoids and interleukin-10 in fenfluramine's effects.

Main Methods:

• Rats were challenged with bacterial lipopolysaccharide (LPS) to induce inflammation.
• Production of interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) was measured.
• In vitro studies assessed direct effects on immune cells.
• Glucocorticoid receptor antagonist (mifepristone) and beta-adrenoceptor antagonist (nadolol) were used to probe mechanisms.

Main Results:

• Fenfluramine suppressed both IL-1beta and TNF-alpha production in a dose-dependent manner.
• The immunosuppressive effects persisted for several hours.
• Fenfluramine did not exert direct immunosuppressive effects on immune cells in vitro.
• Glucocorticoid receptor blockade did not prevent fenfluramine-induced suppression.
• Fenfluramine increased anti-inflammatory interleukin-10 (IL-10) production, but this did not account for TNF-alpha suppression.

Conclusions:

• Acute fenfluramine administration induces an immunosuppressive cytokine phenotype in vivo.
• The observed immunosuppression is independent of direct effects on immune cells and glucocorticoid mediation.
• While IL-10 production is increased, it does not fully explain the suppression of TNF-alpha by fenfluramine.